128 related articles for article (PubMed ID: 25550854)
21. Increased expression of interleukin-23 associated with progression of colorectal cancer.
Hu WH; Chen HH; Yen SL; Huang HY; Hsiao CC; Chuang JH
J Surg Oncol; 2017 Feb; 115(2):208-212. PubMed ID: 27807862
[TBL] [Abstract][Full Text] [Related]
22. Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival.
Nicholson AD; Guo X; Sullivan CA; Cha CH
J Am Coll Surg; 2014 Nov; 219(5):977-87. PubMed ID: 25127509
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
[TBL] [Abstract][Full Text] [Related]
24. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma.
Liu J; Duan Y; Cheng X; Chen X; Xie W; Long H; Lin Z; Zhu B
Biochem Biophys Res Commun; 2011 Apr; 407(2):348-54. PubMed ID: 21396350
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
26. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis.
Matsuda M; Sentani K; Noguchi T; Hinoi T; Okajima M; Matsusaki K; Sakamoto N; Anami K; Naito Y; Oue N; Yasui W
Pathol Int; 2010 Oct; 60(10):673-80. PubMed ID: 20846265
[TBL] [Abstract][Full Text] [Related]
28. CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer.
Zou Y; Chen Y; Wu X; Yuan R; Cai Z; He X; Fan X; Wang L; Wu X; Lan P
Oncol Rep; 2013 Aug; 30(2):659-66. PubMed ID: 23760102
[TBL] [Abstract][Full Text] [Related]
29. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
[TBL] [Abstract][Full Text] [Related]
30. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor receptor 4 as a potential prognostic and therapeutic marker in colorectal cancer.
Li CS; Zhang SX; Liu HJ; Shi YL; Li LP; Guo XB; Zhang ZH
Biomarkers; 2014 Feb; 19(1):81-5. PubMed ID: 24410190
[TBL] [Abstract][Full Text] [Related]
32. Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis.
Sun L; Pan J; Peng L; Fang L; Zhao X; Sun L; Yang Z; Ran Y
Ann Surg Oncol; 2012 Jul; 19(7):2411-9. PubMed ID: 22219064
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and prognostic significance of α5β1-integrin and MMP-14 expressions in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Neoplasma; 2013; 60(3):254-61. PubMed ID: 23373994
[TBL] [Abstract][Full Text] [Related]
34. In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression.
Shimazaki J; Goto Y; Nishida K; Tabuchi T; Motohashi G; Ubukata H; Tabuchi T
Oncology; 2013; 84(6):356-61. PubMed ID: 23689116
[TBL] [Abstract][Full Text] [Related]
35. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
[TBL] [Abstract][Full Text] [Related]
36. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
Li ZP; Han JQ; Meng XW; Yang YF
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic poly(A) binding protein 4 is highly expressed in human colorectal cancer and correlates with better prognosis.
Liu D; Yin B; Wang Q; Ju W; Chen Y; Qiu H; Li J; Peng X; Lu C
J Genet Genomics; 2012 Aug; 39(8):369-74. PubMed ID: 22884093
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator.
De Vita F; Romano C; Orditura M; Galizia G; Martinelli E; Lieto E; Catalano G
J Interferon Cytokine Res; 2001 Jan; 21(1):45-52. PubMed ID: 11177580
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of Interleukin-36s in cancers: A systematic review and meta-analysis.
Zhang R; Jiang M; Huang M; Yang J; Liu Q; Zhao Z; Bai Y; He T; Zhang D; Zhang M
Cytokine; 2023 Dec; 172():156397. PubMed ID: 37922622
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 36α Attenuates Sepsis by Enhancing Antibacterial Functions of Macrophages.
Tao X; Song Z; Wang C; Luo H; Luo Q; Lin X; Zhang L; Yin Y; Cao J
J Infect Dis; 2017 Jan; 215(2):321-332. PubMed ID: 27815380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
